Abstract:The aim of the present study was to investigate the inhibitory effect of specific mimic peptides targeting duck hepatitis B virus polymerase (DHBVP) on duck hepatitis B virus (DHBV) replication in primary duck hepatocytes. Phage display technology (PDT) was used to screen for mimic peptides specifically targeting DHBVP and the associated coding sequences were determined using DNA sequencing. The selected mimic peptides were then used to treat primary duck hepatocytes infected with DHBV in vitro. Infected hepatocytes expressing the mimic peptides intracellularly were also prepared. The cells were divided into mimic peptide groups (EXP groups), an entecavir-treated group (positive control) and a negative control group. The medium was changed every 48 h. Following a 10-day incubation, the cell supernatants were collected. DHBV-DNA in the cellular nucleus, cytoplasm and culture supernatant was analyzed by quantitative polymerase chain reaction (qPCR). Eight mimic peptides were selected following three PDT screening rounds for investigation in the DHBV-infected primary duck hepatocytes. The qPCR results showed that following direct treatment with mimic peptide 2 or 7, intracellular expression of mimic peptide 2 or 7, or treatment with entecavir, the DHBV-DNA levels in the culture supernatant and cytoplasm of duck hepatocytes were significantly lower than those in the negative control (P<0.05). The cytoplasmic DHBV-DNA content of the cells treated with mimic peptide 7 was lower than that in the other groups (P<0.05). In addition, the DHBV-DNA content of the nuclear fractions following the intracellular expression of mimic peptide 7 was significantly lower than that in the other groups (P<0.05). Mimic peptides specifically targeting DHBVP, administered directly or expressed intracellularly, can significantly inhibit DHBV replication in vitro.

A Synthetic Peptide Elicits Antibody Reactive with the Native Duck Hepatitis B Virus Pre-S Protein

Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface protein

Longitudinal Mapping of Hepatitis B Vaccine-Induced B-cell Linear Epitopes in Healthy Individuals

Preparation and identification of duck hepatitis B virus core protein monoclonal antibody

Inhibition of Binding Peptides on Replication of Duck Hepatitis B Virus

Recombinant Vaccinia Virus Expressing Pre-S/S Protein of Duck Hepatitis B Virus and Its Preliminary Use for Treatment of Persistent Infection.

A Virus-Like Particle of the Hepatitis B Virus Pres Antigen Elicits Robust Neutralizing Antibodies and T Cell Responses in Mice.

Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen

Elimination of Immune Tolerance to Hepatitis Virus in an Animal Model.

Solid Matrix-Antibody-antigen Complex Can Clear Viraemia and Antigenaemia in Persistent Duck Hepatitis B Virus Infection.

Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes

Inhibition of Duck Hepatitis B Virus Replication by Mimic Peptides in Vitro.

Preparation and identification of monoclonal antibodies against locale isolated strain of duck hepatitis virus

Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.

Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase

Overexpression and Identification of Hepatitis B Virus Pres Antigen in E. Coli

[Expression of VP1 Gene and ELISA Detection of Antibodies Against Duck Hepatitis Virus].

Characterization of Immune Response of DNA Vaccine Encoding B Cell Epitope

Establishment of hybridoma cell lines producing monoclonal antibodies against hepatitis B virus surface antigens (a, d, and r) and development of sensitive ELISA diagnostic test.

Identification and Characterization of Peptides That Interact with Hepatitis B Virus Via the Putative Receptor Binding Site.

Identification and characterization of a novel nanobody against duck hepatitis A virus type 1